Status:
COMPLETED
Serial Changes in sTREM-1 During Ventilator-associated Pneumonia (VAP)
Lead Sponsor:
Mackay Memorial Hospital
Conditions:
Pneumonia
Eligibility:
All Genders
18-86 years
Brief Summary
Triggering receptor expressed on myeloid cells (TREM)-1 is a recently described molecule that plays an important role in myeloid cell-activated inflammatory responses. The aim of this study was to inv...
Detailed Description
A prospective, interventional study conducted between August 2006 and August 2007 in MICU in Mackay Memorial Hospital, 35 patients with clinically diagnosed VAP were investigated. sTREM-1 was measured...
Eligibility Criteria
Inclusion
- adult patients (older than 18 years)with clinically suspected VAP
Exclusion
- mechanically ventilated patients post cardiopulmonary resuscitation
- patients with end stage diseases with life expectancy less than 3 months
- patients with solid or hematology transplantation
- patients on immunosuppressive agents
Key Trial Info
Start Date :
August 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00976157
Start Date
August 1 2006
End Date
September 1 2008
Last Update
September 15 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mackay Memorial Hospital
Taipei, Taiwan, 106